Gilead Touches Lowest Level Since 2014 Following Q4 Report

Gilead Sciences, Inc. GILD shares are trading lower in Tuesday's after-hours session by $3.13 at $70.00 from Tuesday's closing price of $73.13.

The issue isn't being rewarded for its Q4 beat of $0.11 along with a revenue beat of $116 million. The FY 2017 sales guidance of $22.50-$24.50 million and adjusted EPS of $0.84-$0.91 may not compare with prior estimates.

At the end of Tuesday's session, the issue had cleared the sellers lurking at the $73.00 level, finally pushing through as high as $73.30 before the ending the session at $73.13. The buyers of those shares in that area are now deeply in the red.

In extremely volatile trading, the issue briefly spiked to $75.00 on the initial headlines, but sellers flooded the issue. So far, the ensuing decline has taken the issue to $69.80 and now is trying to remain in the $70.00. The after-market low as of 4:28 p.m. ET coincides with its low for it recent decline that was made on January 24 at $69.78.

Gilead hasn't traded under $70.00 since April 2014.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsTechnicalsAfter-Hours CenterMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!